# IRLA (IRulya Therapeutics Inc.) - SEC EDGAR Financial Statements

> IRulya Therapeutics Inc. reported $106.5M in total assets and a net loss of $106.8M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IRLA
- Markdown: https://convexityos.com/fundamentals/IRLA.md
- SEC CIK: 0001662774
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001662774&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$126.9M | Operating profit |
| Net Income | FY 2025 | -$106.8M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$8.89 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$46.91M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $105.2M | Total debt: $0 |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $35.38M | $18.59M | $9.45M | $25.18M | $60.80M | $61.31M | $30.21M | $10.09M |
| Total Operating Expenses | $58.07M | $57.28M | $34.62M | $52.02M | $90.32M | $78.89M | $39.17M | $12.12M |
| **Operating Income** | -$58.07M | -$57.28M | -$34.62M | -$52.02M | -$90.32M | -$78.89M | -$39.17M | -$12.12M |
| **EBITDA** | -$57.93M | -$57.10M | -$34.30M | -$51.81M | -$89.97M | -$78.56M | -$38.98M | -$12.07M |
| Interest Income | $1.24M | $2.93M | $3.48M | $1.07M | $620K | $2.04M | $2.19M | $806K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $957K |
| Income Before Tax | -$80.77M | -$56.74M | -$31.58M | -$51.94M | -$89.94M | -$76.85M | -$36.98M | -- |
| Income Tax Expense | $3.21M | $87K | -$197K | -$284K | $0 | $0 | $0 | $0 |
| **Net Income** | -$83.98M | -$56.83M | -$31.39M | -$51.66M | -$89.94M | -$76.85M | -$36.98M | -$12.48M |
| Basic EPS | -$3,360.00 | -$2,620.00 | -$1,680.00 | -$3,080.00 | -$6,060.00 | -$5,260.00 | -$3,880.00 | -$7,420.00 |
| **Diluted EPS** | -$3,360.00 | -$2,620.00 | -$1,680.00 | -$3,080.00 | -$6,060.00 | -$5,260.00 | -$3,880.00 | -$7,420.00 |
| Basic Shares Outstanding | 25.0K | 21.6K | 18.6K | 16.7K | 14.9K | 14.6K | 9.5K | 1.7K |
| Diluted Shares Outstanding | 25.0K | 21.6K | 18.6K | 16.7K | 14.9K | 14.6K | 9.5K | 1.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.85M | $5.46M | $6.84M | $12.60M | $8.08M | $6.55M | $8.14M | $5.83M |
| Total Operating Expenses | $13.14M | $79.78M | $14.59M | $19.35M | $13.43M | $10.43M | $14.86M | $12.01M |
| **Operating Income** | -$13.14M | -$79.78M | -$14.59M | -$19.35M | -$13.43M | -$10.43M | -$14.86M | -$12.01M |
| **EBITDA** | -$13.13M | -$79.74M | -$14.55M | -$19.31M | -$13.39M | -$10.39M | -$14.83M | -$12.00M |
| Interest Income | $1.02M | $584K | $160K | $227K | $300K | $311K | $406K | $536K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -$14.98M | -- |
| Income Tax Expense | -$302K | $75K | -$5.34M | $3.15M | -$46K | $67K | $47K | $7.0K |
| **Net Income** | -$27.74M | -$75.49M | $35.91M | -$39.46M | -$13.44M | -$16.05M | -$15.03M | -$12.46M |
| Basic EPS | -$2.31 | -$12.31 | $720.00 | -- | -$49.83 | -$68.75 | -$684.00 | -- |
| **Diluted EPS** | -$2.31 | -$12.31 | $576.00 | -- | -$49.83 | -$68.75 | -$684.00 | -- |
| Basic Shares Outstanding | 12.0M | 6.1M | 45.6K | -- | 269.8K | 233.4K | 22.0K | -- |
| Diluted Shares Outstanding | 12.0M | 6.1M | 46.0K | -- | 269.8K | 233.4K | 22.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.81M | $6.21M | -- | $40.59M | $29.45M | -- | $51.21M | $24.87M |
| Short-Term Investments | $11.94M | $34.57M | $54.31M | $45.60M | $37.08M | $66.98M | $48.65M | $46.84M |
| **Cash & Short-Term Investments** | $17.80M | $40.80M | $75.10M | $90.20M | $106.8M | $133.8M | $99.90M | $71.72M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- | -- | -- |
| Other Current Assets | $54K | $84K | $81K | $276K | $367K | $694K | $688K | $68K |
| **Total Current Assets** | $22.90M | $44.04M | $77.44M | $93.75M | $111.7M | $137.9M | $106.1M | $72.58M |
| Property, Plant & Equipment, Net | $595K | $315K | $234K | $393K | $263K | $427K | $709K | $283K |
| Goodwill | -- | $0 | $17.62M | $0 | $0 | -- | -- | -- |
| Intangible Assets | $67.82M | $60.05M | $63.67M | $5.90M | $0 | -- | -- | -- |
| Long-Term Investments | -- | -- | $0 | $3.58M | $19.93M | $50.46M | $16.76M | -- |
| Other Non-Current Assets | $1.76M | $9.58M | $8.54M | $0 | $194K | $39K | $217K | $10K |
| **Total Non-Current Assets** | $70.63M | $70.44M | $90.46M | $10.16M | $21.55M | $51.60M | $18.31M | $293K |
| **Total Assets** | $93.52M | $114.5M | $167.9M | $103.9M | $133.2M | $189.5M | $124.4M | $72.88M |
| Accounts Payable | $2.22M | $2.90M | $2.03M | $570K | $4.91M | $3.56M | $3.08M | $495K |
| Short-Term Debt | $18.03M | $0 | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $43.23M | $7.28M | $9.57M | $3.07M | $14.22M | $17.00M | $8.89M | $1.46M |
| Long-Term Debt | -- | $14.32M | $13.43M | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $1.57M | $685K | $587K | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $86.01M | $77.05M | $73.24M | $248K | $420K | $208K | $0 | $0 |
| **Total Liabilities** | $129.2M | $84.33M | $82.82M | $3.32M | $14.64M | $17.20M | $8.89M | $1.46M |
| **Total Debt (incl. Leases)** | $18.47M | $14.81M | $13.81M | $377K | $1.16M | $446K | -- | -- |
| Common Stock | $0 | $44K | $43K | $36K | $30K | $29K | $27K | $3.0K |
| Retained Earnings | -$460.5M | -$376.5M | -$319.6M | -$288.3M | -$236.6M | -$146.7M | -$69.81M | -$32.83M |
| Accumulated Other Comp. Income | $5.75M | -$35K | $3.05M | -$289K | -$79K | $313K | $60K | -$49K |
| **Total Stockholders' Equity** | -$35.71M | $30.15M | $85.08M | $100.6M | $118.6M | $172.3M | $115.5M | -$32.63M |
| Total Equity | -$35.71M | $30.15M | $85.08M | $100.6M | $118.6M | $172.3M | $115.5M | -$32.63M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $39.82M | $116.0M | $18.16M | $5.81M | $6.45M | $16.83M | $7.77M | $6.21M |
| Short-Term Investments | $65.42M | $0 | $0 | $11.94M | -- | -- | -- | $34.57M |
| **Cash & Short-Term Investments** | $105.2M | $116.0M | $18.20M | $17.80M | $26.30M | $34.70M | $31.60M | $40.80M |
| Other Current Assets | $65K | $393K | $24K | $54K | $96K | $55K | $32K | $84K |
| **Total Current Assets** | $106.3M | $123.4M | $25.58M | $22.90M | $29.20M | $37.34M | $33.83M | $44.04M |
| Property, Plant & Equipment, Net | $69K | $506K | $550K | $595K | $616K | $573K | $448K | $315K |
| Goodwill | -- | -- | -- | -- | $0 | -- | -- | $0 |
| Intangible Assets | $0 | $0 | $0 | $67.82M | $67.73M | $67.57M | $62.37M | $60.05M |
| Other Non-Current Assets | $106K | $78K | $78K | $1.76M | $11.87M | $11.22M | $9.95M | $9.58M |
| **Total Non-Current Assets** | $175K | $584K | $1.04M | $70.63M | $80.70M | $79.86M | $73.26M | $70.44M |
| **Total Assets** | $106.5M | $124.0M | $26.62M | $93.52M | $109.9M | $117.2M | $107.1M | $114.5M |
| Accounts Payable | $1.45M | $4.64M | $5.39M | $2.22M | $3.40M | $1.76M | $3.01M | $2.90M |
| Short-Term Debt | $0 | $0 | $0 | $18.03M | $17.52M | -- | -- | $0 |
| **Total Current Liabilities** | $7.22M | $8.50M | $8.77M | $43.23M | $26.04M | $7.47M | $8.36M | $7.28M |
| Long-Term Debt | -- | -- | -- | -- | -- | $16.99M | $15.27M | $14.32M |
| Other Non-Current Liabilities | $556K | $716K | $1.20M | $1.57M | $778K | $745K | $716K | $685K |
| **Total Non-Current Liabilities** | $21.15M | $7.01M | $2.18M | $86.01M | $82.80M | $98.01M | $80.15M | $77.05M |
| **Total Liabilities** | $28.37M | $15.51M | $10.95M | $129.2M | $108.8M | $105.5M | $88.51M | $84.33M |
| **Total Debt (incl. Leases)** | $0 | $0 | $406K | $18.47M | $17.99M | $17.49M | $15.75M | $14.81M |
| Common Stock | $1.0K | $1.0K | $14K | $0 | $54K | $53K | $44K | $44K |
| Retained Earnings | -$527.8M | -$500.0M | -$424.5M | -$460.5M | -$421.0M | -$407.6M | -$391.5M | -$376.5M |
| Accumulated Other Comp. Income | -$17K | $4.25M | $4.61M | $5.75M | $6.29M | $6.16M | $1.96M | -$35K |
| **Total Stockholders' Equity** | -$65.70M | -$35.32M | $15.67M | -$35.71M | $1.06M | $11.74M | $18.58M | $30.15M |
| Total Equity | -$65.70M | -$35.32M | $15.67M | -$35.71M | $1.06M | $11.74M | $18.58M | $30.15M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$83.98M | -$56.83M | -$31.39M | -$51.66M | -$89.94M | -$76.85M | -$36.98M | -$12.48M |
| Depreciation & Amortization | $142K | $186K | $322K | $204K | $344K | $332K | $188K | $51K |
| Stock-Based Compensation | $5.11M | $4.75M | $5.22M | $16.62M | $29.85M | $14.47M | $2.06M | $155K |
| Change in Payables | -$940K | $927K | -$288K | -$5.94M | $1.36M | $480K | $2.58M | -$23K |
| **Operating Cash Flow** | -$41.42M | -$31.90M | -$18.29M | -$44.04M | -$62.93M | -$50.82M | -$33.28M | -$11.70M |
| Capital Expenditure | -$352K | -$257K | -$160K | -$133K | -$180K | -$52K | -$55K | -$212K |
| **Free Cash Flow** | -$41.78M | -$32.16M | -$18.45M | -$44.17M | -$63.11M | -$50.87M | -$33.33M | -$11.91M |
| Purchases of Investments | -$34.42M | -$89.56M | -$113.8M | -$75.02M | -$38.79M | -$187.1M | -$135.4M | -$55.24M |
| Sales & Maturities of Investments | -- | -- | $111.2M | $82.49M | $97.92M | $134.8M | $117.7M | $8.70M |
| **Investing Cash Flow** | $23.23M | $21.91M | -$5.76M | $18.00M | $58.95M | -$52.43M | -$17.75M | -$46.75M |
| Common Stock Issued | -- | -- | $0 | $608K | $0 | -- | -- | -- |
| **Financing Cash Flow** | $17.91M | -$4.78M | $143K | $707K | $6.81M | $118.9M | $77.37M | $75.93M |
| **Net Change in Cash** | -$403K | -$14.54M | -$23.83M | -$25.14M | $2.88M | $15.63M | $26.34M | $17.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$27.74M | -$75.49M | $35.91M | -$39.46M | -$13.44M | -$16.05M | -$15.03M | -$12.46M |
| Depreciation & Amortization | $15K | $41K | $36K | $39K | $36K | $35K | $32K | $16K |
| Stock-Based Compensation | $1.64M | $12.09M | $1.29M | $1.19M | $1.25M | $1.27M | $1.39M | $1.12M |
| Change in Payables | -$3.02M | $260K | $5.91M | -$1.15M | $1.63M | -$1.44M | $22K | $1.35M |
| **Operating Cash Flow** | -$9.84M | -$18.89M | -$7.63M | -$10.48M | -$9.93M | -$11.41M | -$9.60M | -$7.55M |
| Capital Expenditure | -$71K | $0 | $0 | -$4.0K | -$74K | -$126K | -$148K | -$133K |
| **Free Cash Flow** | -$9.91M | -$18.89M | -$7.63M | -$10.48M | -$10.00M | -$11.54M | -$9.75M | -$7.68M |
| Purchases of Investments | -$64.92M | $0 | $0 | -$4.92M | -$15.71M | -$11.84M | -$1.95M | $0 |
| **Investing Cash Flow** | -$67.79M | $8.00M | $12.00M | $8.07M | -$1.78M | $6.04M | $10.90M | $10.87M |
| **Financing Cash Flow** | -$10K | $108.9M | $9.44M | $2.03M | $1.38M | $14.41M | $87K | $0 |
| **Net Change in Cash** | -$76.16M | $97.82M | $12.35M | -$643K | -$10.37M | $9.05M | $1.56M | $3.54M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -188.5% | -36.9% | -51.4% | -75.8% | -44.6% | -32.0% | -- |
| Return on Assets (ROA) | -89.8% | -49.6% | -18.7% | -49.7% | -67.5% | -40.6% | -29.7% | -17.1% |
| Current Ratio | 0.53x | 6.05x | 8.09x | 30.55x | 7.85x | 8.11x | 11.93x | 49.82x |
| Quick Ratio | 0.41x | 5.61x | 7.85x | 29.39x | 7.51x | 7.87x | 11.23x | 49.22x |
| Debt to Equity | -- | 0.49x | 0.16x | 0.00x | 0.01x | 0.00x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -210.8% | -- | -5380.5% | -417.8% | -326.7% | -188.5% |
| Return on Assets (ROA) | -100.3% | -74.6% | -124.1% | -89.8% | -51.8% | -41.8% | -56.7% | -49.6% |
| Current Ratio | 14.72x | 14.52x | 2.92x | 0.53x | 1.12x | 5.00x | 4.05x | 6.05x |
| Quick Ratio | 14.57x | 13.65x | 2.08x | 0.41x | 1.01x | 4.65x | 3.78x | 5.61x |
| Debt to Equity | -- | -- | 0.03x | -- | 16.99x | 1.49x | 0.85x | 0.49x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
